Navigation Links
Sanofi Pasteur Announces Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Infants and Children
Date:10/14/2009

lease see full U.S. Prescribing Information at www.vaccineplace.com/products.

About Influenza Vaccine Production at Sanofi Pasteur

Sanofi Pasteur operates influenza vaccine production facilities in Val de Reuil, France and in Swiftwater, Pa. (U.S.). All Sanofi Pasteur influenza vaccine facilities have been designed and built to be able to switch from seasonal influenza vaccine production to pandemic influenza vaccine production.

Sanofi Pasteur produces approximately 40 percent of the influenza vaccines distributed worldwide and more than 45 percent of the influenza vaccines distributed in the U.S. for the 2008-2009 influenza season. More information about Sanofi Pasteur's pandemic preparedness efforts can be found at www.pandemic.influenza.com.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2008, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information, please visit: http://www.sanofipasteur.com or www.sanofipasteur.us.

Pr
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
8. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
9. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
10. Sanofi-aventis Stands Behind the Safety of Lantus(R)
11. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... SHANGHAI , July 1, 2015 Qiming ... Hu to Managing Partner effective immediately. ... He has lead and participated in many Qiming healthcare ... leaders in the Chinese market. Qiming, s success in ... and he has distinguished himself with his outstanding advocacy ...
(Date:7/1/2015)... , July 1, 2015 Lupin ... Bring Total Number of MPP Sub-licensees to Fourteen ... Patent Pool (MPP) announced the rapid expansion of its network ... than 50 projects to develop MPP-licensed antiretrovirals (ARVs). New companies ... (DTG), a promising new HIV medicine the MPP licensed from ...
(Date:7/1/2015)... Boston Scientific Corporation (NYSE: BSX ) will webcast its ... second quarter ended June 30, 2015 on Thursday, July 23, ... be hosted by Mike Mahoney , president and chief ... and chief financial officer. A live webcast of ... website. Webcast registration is available on the Investor Relations section ...
Breaking Medicine Technology:Qiming Announces the Promotion of William Hu to Managing Partner 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2
... Reportlinker.com announces that a new market research report is available in its catalogue: , ... Market Analysis 2010-2025 , , , ... Reports details , ... in this diverse market with high, growing demand worldwide? , , , ...
... , May 4 Emdeon Inc. (NYSE: ... revenue and payment cycle management solutions, today announced a ... solutions company delivering more accurate, timely and comprehensive data ... will be able to offer its 1,200 healthcare payer ...
Cached Medicine Technology:Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 2Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 3Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 4Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 5Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 6Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 7Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 8Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 9Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 10Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 11Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 12Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 13Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 14Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 15Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 16Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025 17Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality 2Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality 3Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality 4Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality 5
(Date:7/1/2015)... ... July 01, 2015 , ... Sir Fazle Hasan Abed, BRAC’s founder ... today. Sir Fazle has been recognised for his outstanding contribution to enhancing the world's ... Quinn, President of the World Food Prize Foundation, announced this year’s winner at a ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... new members to their industry leading Scientific Advisory Board. LRF’s volunteer Scientific Advisory ...
(Date:7/1/2015)... Tokyo, Japan (PRWEB) , ... July 01, 2015 ... ... August 2015 of a new extraction plant for Linablue®, Spirulina-derived natural blue food ... Earthrise Nutritionals, LLC, the DIC Group’s U.S. Spirulina* production base, began in May ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... cancer enterprise of Hospital Corporation of America (HCA), as it further expands its ... announced today. , With this new partnership, OncLive’s editorial and marketing teams ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse Show hosted by ... 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event will ... zoo, an Elvis impersonator, a silent auction and concessions. , Horses and riders from ...
Breaking Medicine News(10 mins):Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 2Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 3Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 4Health News:Lymphoma Research Foundation Welcomes New Scientific Advisory Board Members 5Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 2Health News:DIC Strengthens Its Position as the Global Leader for Natural Blue Food Coloring 3Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3
... on gum bacteria, scientists had been able to use ... the oral cavity. ,The dental samples obtained from ... light (380 to 520nm). The light had selectively killed ... dental plaque samples obtained from patients. Medium strength light ...
... a research covering 218 diabetic patients and 799 non-diabetic ... scientists of Epidemiologic Research and Information Center, Seattle, US ... having a urinary tract infection for women who have ... annual follow up of testing for hemoglobin A1c, urine ...
... drug market watchdog Food and Drug Administration had announced a ... the class of non-steroidal anti-inflammatory drugs that are sold with ... withdrawal of the drug Bextra (valdecoxib) from Pfizer, Inc. ... as FDA had reports that the overall risk associated with ...
... pattern of rising early from bed in the mornings have ... ,The behavior is called familial advanced sleep phase syndrome ... said to be the phenotype of the gene PER2. The ... phosphorylation site in the casein kinase I (CKI) domain of ...
... Institute Maryland USA had found out a gene that is ... syndrome. ,The disease is caused by a point ... of the major genes that lead to the physiology of ... individual with the disease have severe abnormalities in the nuclear ...
... had pointed out that excessive exposure to television at the ... behavior.// ,A child is considered to be a bully ... be done by actual physical attack on others or by ... not read aloud to their children, or provide them with ...
Cached Medicine News:
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
Medicine Products: